Form 4: Candel Therapeutics Director Sells Shares in Multiple Transactions

Estuardo Aguilar-Cordova, a director and 10% owner of Candel Therapeutics, Inc., executed multiple sales of company stock between October 30 and November 1, 2024.

Summary

• Estuardo Aguilar-Cordova, a director and 10% owner of Candel Therapeutics, sold shares of CADL stock in multiple transactions.
• On October 30, 2024, Aguilar-Cordova sold 6,000 shares at a price of $5.38 per share.
• On October 31, 2024, Aguilar-Cordova sold 7,500 shares at a price of $5.30 per share.
• On November 1, 2024, Aguilar-Cordova sold 7,500 shares at a price of $5.27 per share.
• Laura K. Aguilar, also a director and 10% owner, signed the document on November 1, 2024.
• Following these transactions, Estuardo Aguilar-Cordova directly owns 896,012 shares and indirectly owns 853,943 shares through the LKA 2022 Revocable Trust.
• Additionally, Estuardo Aguilar-Cordova indirectly owns 2,074,942 shares through the Estuardo Aguilar-Cordova 2020 Irrevocable Trust, 2,013,100 shares through the Laura K. Aguilar 2020 Irrevocable Trust, and 171,335 shares jointly with Laura K. Aguilar.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by a company director, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies.

Stakeholder Impact

• The stock sales by a director may cause short-term fluctuations in the stock price, potentially impacting shareholders.

Key Dates